Inogen Stock

Inogen ROE

The Return on Equity (ROE) of Inogen (INGN) as of Jul 16, 2026 is -11.83 %. In the previous year, Return on Equity (ROE) was -20.64 % — a change of -42.67% (higher).

ROE

-11.83 %

YoY

-42.67%

Last updated:

In 2026, Inogen's return on equity (ROE) was -11.83 %, a -42.67% increase from the -20.64 % ROE in the previous year.

Access this data via the Eulerpool API

Inogen Stock analysis

What does Inogen do? Inogen Inc. is an American company that specializes in the development and manufacturing of oxygen concentrators. The company was founded in 2001 and is headquartered in Goleta, California. Inogen has become a market leader in portable oxygen concentrators in the American market. The company offers high-quality products and services to improve the lives of patients with chronic lung problems. Inogen focuses on improving the quality of life by developing and manufacturing high-quality, durable, and reliable portable oxygen concentrators that integrate all necessary features for optimal mobility and freedom. It offers various products and services for patients, doctors, insurance companies, and community centers. Some of its products include the Inogen One G5, Inogen One G4, Inogen TAV, Inogen Carry Bag, and Inogen Battery. In summary, Inogen Inc. is a specialized company in the development and manufacturing of oxygen concentrators, with a focus on improving the lives of patients with chronic lung problems through high-quality portable solutions. Inogen is one of the most popular companies on Eulerpool.

ROE Details

Decoding Inogen's Return on Equity (ROE)

Inogen's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Inogen's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Inogen's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Inogen’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Inogen stock

Return on Equity (ROE) of Inogen is -11.83 % in 2026.

Access this data via the Eulerpool API

Profitability — Inogen

All Key Metrics — Inogen